WillItSurvive
Medical technology and health companies · subsidiary of New Mountain Capital (PE sponsor; legal entity is Ciox Health, LLC d/b/a Datavant Group following 2021 merger) · United States

Datavant

datavant.com ↗

Datavant links health records across hospitals and payers without holding the data itself.

Hard to displace
Assessed 22 July 2026 · Evidence as of 22 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 22 July 2026 · Checkable from September 4, 2026 · Every call on the record Checkpoint: Fairness hearing on $900K data breach settlement
The call

Datavant sits on network relationships and regulatory positioning that took a decade to build, while AI nibbles at its slower, labor-heavy record retrieval edge.

Datavant is a middleman that helps hospitals, insurance companies, and drugmakers share patient medical records in a legal and safe way. It is hard to copy because three things work together: first, it takes legal responsibility for protecting patient privacy in ways that new competitors and artificial intelligence systems cannot; second, it has signed contracts with 80,000 hospitals and nearly every major health insurer over ten years, which a new company would need years to rebuild; third, it stays neutral between different health systems instead of picking sides, which means the companies that make electronic health records (like Epic) or manage drug data (like IQVIA) cannot do the same without losing their own customers. A younger competitor called Honey Health is using artificial intelligence to automate the boring work of pulling old medical records, which could squeeze Datavant's profits on that task, though it does not threaten the core business. The one thing that could change everything: if Datavant struggles to combine three companies it bought in the last year (Aetion, Ontellus, and DigitalOwl), or if its owners decide they need to cash out and a buyer tries to merge it with another large company, disrupting those neutral relationships.

Why
01
AI pressure: Honey Health. AI-native tools automate record retrieval and fulfillment, squeezing margins in Datavant's legacy Ciox business, not its core network. Could AI do the core job? Unlikely.
02
Bigger players: Epic/Oracle Health. Epic could try a neutral cross-EHR data layer but that would undercut its own lock-in, so it has not moved. Could a giant copy it? No, they are blocked.
03
What protects it. HIPAA de-identification licenses plus contracts with 80,000+ hospitals and nearly all US payers, built over a decade.
What would change this call
Honey Health or similar announces named hospital/health-system contracts won from Ciox/Datavant fulfillment. Would show AI-native rivals converting margin pressure into actual account losses.
Epic or Oracle Health launches a neutral cross-EHR data-linkage product open to non-Epic systems. Would show the neutral-broker moat eroding from an incumbent previously structurally blocked.
New Mountain Capital sells Datavant to an EHR vendor or IQVIA-like strategic buyer. Would show the neutrality positioning being sacrificed for an exit.
Key numbers
  • 80,000+ hospitals and clinics connected (2026-05-17)
  • 64 million annual medical record retrievals (2026-05-17)
  • Revenue estimated $800M to $1.9B (2026-07-20)
Named risks
  • AI-native competitors eroding margins in labor-intensive record retrieval segment. Severity: medium
  • Integration execution risk from three acquisitions (Aetion, Ontellus, DigitalOwl) within 12 months. Severity: medium
  • Final court hearing September 4, 2026 on $900,000 data-breach settlement, reputational exposure. Severity: medium
  • No IPO signal despite PE ownership since 2021, creating liquidity uncertainty for investors. Severity: low
  • Inconsistent public data on headcount, revenue and HQ location undermines transparency. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Honey Healthlosing toAI-native record retrieval undercutting Datavant's legacy Ciox fulfillment segment as of 2026
IQVIAcontestingNamed alongside Datavant as CB Insights peer leader in health-data/interoperability, June 2026
HealthVeritycontestingCited as direct competitor in de-identified linked-data space, March 2026
TriNetXcontestingNamed as peer specialist in de-identification and linkage niche, 2026
Epic/Oracle Healthgaining onStructurally barred from neutral cross-EHR brokering by its own lock-in model, per HFMA analysis Dec 2025
Questions people ask
Is Datavant profitable in 2026?
Datavant is privately held with no audited financials disclosed. Third-party estimates of annual revenue range widely from $800M-$1B (canvasbusinessmodel.com, March 2026) to $1.9B (ZoomInfo, July 2026), but profitability has not been confirmed by any public source as of mid-2026.
Who owns Datavant?
Datavant has been backed by private equity since its June 2021 merger with Ciox Health, a deal valued at roughly $7 billion. New Mountain Capital remains the lead sponsor as of August 2025, alongside Sixth Street, Goldman Sachs Asset Management and others. No IPO has been filed as of mid-2026.
Could AI replace Datavant's medical record retrieval business?
AI-native competitors like Honey Health are automating end-to-end record fulfillment, pressuring Datavant's legacy Ciox-derived Release of Information segment. Datavant responded by acquiring AI-driven DigitalOwl in October 2025, suggesting margin pressure in retrieval rather than displacement of its core compliance network.
Is Datavant laying off employees?
Revelio Labs estimates Datavant's global headcount fell 3.9% to 12,046 by December 2025 from 12,532 in 2023, even as the company opened a new Galway, Ireland R&D center in April 2026 and hired 100 staff there, targeting 125 by end-2027.
Who is Datavant's biggest competitor?
CB Insights names Datavant a category Leader alongside peers IQVIA, Tempus and Komodo Health (June 2026 ranking). In its core de-identification and linkage niche, HealthVerity and TriNetX are frequently cited direct competitors; in record retrieval, AI-native Honey Health is the emerging challenger.
Will Datavant go public soon?
As of June 2026, pre-IPO marketplaces Forge Global and Nasdaq Private Market confirm Datavant remains private with no announced listing plans. New Mountain Capital has held its stake since the 2021 Ciox merger with no confirmed exit timeline.
Timeline
  • 2026-06-25Joined the Agentic AI Foundation alongside AWS, Anthropic, Google, Microsoft, OpenAI
  • 2026-06-03Joined the AIUC-1 Consortium for agentic AI safety and security standards
  • 2026-04-29Opened Global R&D Centre in Galway, Ireland; 100 hires against 125 target by 2027
  • 2026-04-17$900,000 data-breach class-action settlement received preliminary court approval
  • 2025-10Closed acquisition of DigitalOwl, AI-driven medical record analysis firm
  • 2025-08Completed acquisition of Ontellus, forming new Legal and Insurance business vertical
  • 2025-07Completed acquisition of Aetion, real-world-evidence analytics firm
  • 2024-05Kyle Armbrester became CEO of Datavant
  • 2021-06Datavant merged with Ciox Health in deal valued at approximately $7 billion
  • 2018Series A raised approximately $40.5 million led by Roivant Sciences
Revision history
22 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Epic SystemsPro MedicusCochlear Limited
More in Medical technology and health companies →
Sources